Review article · 2025 · Open access

Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control Trials

Lorenzo Moccia, Francesca Bardi, Maria Benedetta Anesini, Sara Barbonetti, Georgios Demetrios Kotzalidis, Sara Rossi, Romina Caso, Flavia Grisoni, Giuseppe Mandracchia, Stella Margoni, Tommaso Callovini, Delfina Janiri and 11 more

Biomedicines, 13(3), 540 · Published 21 February 2025 · DOI 10.3390/biomedicines13030540

Open PDFView at the publisherCite this paper

In brief

“Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control Trials” is a 2025 review article by Lorenzo Moccia and 22 co-authors, published in Biomedicines. OpenAlex counts 9 citations as of 20 November 2026, which puts it in the top 4% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Biomedicines.

Citations
9
Most cited in
2026 (5)
Field-weighted impact
0.98
References
233
Authors
23

Abstract

Background/Objectives: While positive symptoms of schizophrenia are often satisfactorily controlled, negative symptoms are difficult to treat, persisting despite treatment. Different strategies have been devised to deal with this problem. We aimed to review drug treatment for negative symptoms of schizophrenia in controlled trials of marketed drugs. Methods: We searched the PubMed database and the resulting records’ reference lists to identify eligible trials using schizophrenia[ti] AND “negative symptom*”[ti] as a search strategy. We determined eligibility through Delphi rounds among all authors. Results: On 11 February 2025, we identified 1485 records on PubMed and 3 more from reference lists. Eligible were 95 records. Most studies were double-blind, randomized controlled trials, carried-out in add-on in patients stabilized with antipsychotics. Other antipsychotics were the most frequent comparators, followed by antidepressants, and recently, antioxidants are gaining importance in trials. Many trials, especially those conducted in the Western world, found no significant effects compared to placebo, while most Iranian studies were positive, although not with a strong effect size. Conclusions: Current research has contributed little to progress in the treatment of the negative symptoms of schizophrenia. The reason might reside in the absence of knowledge of the mechanisms whereby these symptoms are generated, which prevents us from designing possibly effective treatment strategies, and/or to the chronicity of negative symptoms, as they are the first to be established even when they do not become fully apparent.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Moccia, L., Bardi, F., Anesini, M. B., Barbonetti, S., Kotzalidis, G. D., Rossi, S., Caso, R., Grisoni, F., Mandracchia, G., Margoni, S., Callovini, T., Janiri, D., Mazza, M., Simonetti, A., Montanari, S., Autullo, G., Camardese, G., Pepe, M., Di Nicola, M., . . . on behalf of the Gemelli RePsy Study Group. (2025). Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control Trials. Biomedicines, 13(3), 540. https://doi.org/10.3390/biomedicines13030540

MLA 9

Moccia, Lorenzo, et al. “Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control Trials.” Biomedicines, vol. 13, no. 3, 2025, p. 540. https://doi.org/10.3390/biomedicines13030540.

Chicago

Moccia, Lorenzo, Francesca Bardi, Maria Benedetta Anesini, Sara Barbonetti, Georgios Demetrios Kotzalidis, Sara Rossi, Romina Caso, et al. 2025. “Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control Trials.” Biomedicines 13 (3): 540. https://doi.org/10.3390/biomedicines13030540.

Harvard

Moccia, L. et al. (2025) ‘Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control Trials’, Biomedicines, 13(3), p. 540. doi:10.3390/biomedicines13030540.

IEEE

L. Moccia et al., “Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control Trials,” Biomedicines, vol. 13, no. 3, p. 540, 2025, doi: 10.3390/biomedicines13030540.

BibTeX

@article{moccia2025pharmacological,
  title     = {{Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control Trials}},
  author    = {Moccia, Lorenzo and Bardi, Francesca and Anesini, Maria Benedetta and Barbonetti, Sara and Kotzalidis, Georgios Demetrios and Rossi, Sara and Caso, Romina and Grisoni, Flavia and Mandracchia, Giuseppe and Margoni, Stella and Callovini, Tommaso and Janiri, Delfina and Mazza, Marianna and Simonetti, Alessio and Montanari, Silvia and Autullo, Gianna and Camardese, Giovanni and Pepe, Maria and Di Nicola, Marco and Di Giorgio, Vassilij and Conti, Fabio and Sani, Gabriele and on behalf of the Gemelli RePsy Study Group},
  journal   = {Biomedicines},
  year      = {2025},
  volume    = {13},
  number    = {3},
  pages     = {540},
  doi       = {10.3390/biomedicines13030540},
  url       = {https://doi.org/10.3390/biomedicines13030540}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • schizophrenia
  • negative symptoms
  • pharmacotherapy
  • antipsychotic drugs
  • antidepressants
  • antioxidants
  • adjunctive therapy
  • placebo response

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Moccia, L., Bardi, F., Anesini, M. B., Barbonetti, S., Kotzalidis, G. D., Rossi, S., Caso, R., Grisoni, F., Mandracchia, G., Margoni, S., Callovini, T., Janiri, D., Mazza, M., Simonetti, A., Montanari, S., Autullo, G., Camardese, G., Pepe, M., Di Nicola, M., . . . on behalf of the Gemelli RePsy Study Group. (2025). Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control Trials. Biomedicines, 13(3), 540. https://doi.org/10.3390/biomedicines13030540

How many times has this paper been cited?

9 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Biomedicines: sign in and open the PDF from this page.

Who wrote this paper?

Lorenzo Moccia, Francesca Bardi, Maria Benedetta Anesini, Sara Barbonetti, Georgios Demetrios Kotzalidis, Sara Rossi, Romina Caso, Flavia Grisoni, Giuseppe Mandracchia, Stella Margoni, Tommaso Callovini, Delfina Janiri and 11 more.

What is the DOI of this paper?

10.3390/biomedicines13030540, permanently at https://doi.org/10.3390/biomedicines13030540. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.